相关实验视频

Updated: Jan 13, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

在CSC中用于下值微脉冲激光器的新型全眼镜策略:两年的功能和形态结果

Małgorzata Latalska¹, Sławomir Dresler^2,3, Magdalena Wójciak²

¹Chair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland.

Journal of clinical medicine

|January 10, 2026

概括

全眼微脉冲激光疗法 (MPLT) 有效治疗中枢血清性胆色素变异症 (CSC),改善视力和减少长期的视网膜厚度. 复发性CSC显示出较弱的结果,表明疾病复发是负面的预后因素.

科学领域:

眼科医生眼科眼科
视网膜疾病视网膜疾病
激光疗法是一种激光疗法.

背景情况:

中央血清性胆红蛋白病变 (CSC) 是一种常见的视网膜疾病.
低值微脉冲激光疗法 (MPLT) 是 CSC 的新兴治疗选择.
对各种CSC形式评估一种全新的全局MPLT战略至关重要.

研究的目的:

评估全球性MPLT在急性 (aCSC),慢性 (cCSC) 和复发性 (rCSC) 中的长期功能和结构结果.
在CSC患者中确定新型全球MPLT策略的有效性.

主要方法:

对41名中枢神经瘤患者和14名接受全毛细胞下值MPLT的对照进行了回顾性研究.
测量包括最佳校正的视力敏度 (BCVA),视网膜敏感度 (RetSens),中枢胆道厚度 (CCT) 和病血管直径在基线和治疗后24个月.
对aCSC的平均随访时间为24.0个月,对cCSC/rCSC的平均随访时间为18.6个月.

主要成果:

在100%的aCSC,86.66%的cCSC和63.63%的rCSC病例中发生了完全的脑下液分离.
在两年后,在所有组中观察到BCVA显著改善 (p = aCSC的0.005).
在aCSC (p = 0.001) 和cCSC (p = 0.046) 中,RetSens有所改善,而在所有CSC组中,CCT,CRT和包血管直径显著下降 (p < 0.05).

结论:

全球性MPLT是一种安全有效的CSC治疗方法,可显著改善长期的功能和结构.
该疗法在急性和慢性CSC病例中特别有效.
复发性CSC显示出较差的结果,这表明疾病复发是一个负面的预后因素.

关键词:

中央血清胆色素变异症 (Central Serous Chorioretinopathy) 是一种血清胆色素变异症.冠状腺厚度冠状腺厚度微脉冲激光器是一种微脉冲激光器.帕奇船只的船只全球性治疗治疗.视网膜的敏感性下腺体液体的使用情况船舶密度是指船舶的密度.

更多相关视频

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Published on: January 21, 2018

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...